用内镜超声波导向排水和米诺环素化物注射治疗的症状性肝囊:一个病例报告
Kensuke Hoshi1, Naoki Okano2, Yoichiro Sato2
1Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, 6-11-1, Omori-nishi, Ota-ku, Tokyo, 143-8541, Japan. kensuke.hoshi@med.toho-u.ac.jp.
Clinical journal of gastroenterology
|August 5, 2024
概括
透视式超声波导向排水和米诺环素化物注射有效地治疗了症状性肝囊. 这种微创手术方法减少了囊大小,改善了患者的症状,在手术复杂时提供了替代方案.
科学领域:
- 胃肠病学 胃肠病学
- 干预性内镜检查是干预性的内镜检查.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 症状性肝囊可以引起显著的不适,并带来治疗挑战.
- 传统的穿皮排水带有肠道穿孔等风险,需要使用替代的最小侵入性技术.
研究的目的:
- 为了评估跨胃内镜超声波导向肝囊排水与米诺环素化物注射相结合的疗效.
- 为治疗复杂肝囊提供一种最小侵入性的替代方案.
主要方法:
- 一名72岁的男性患有大型症状性肝囊,接受了超声波引导的跨胃内镜排水.
- 在最初的排水后,米诺环林化物通过鼻腔排水管注射到囊中.
- 使用计算机断层扫描 (CT) 监测囊的反应.
主要成果:
- 肝囊最初为130毫米,在治疗后的9个月内显著减少到12毫米.
- 病人经历了显著改善的表胃疼痛和其他症状.
- 这项程序在技术上是可行的,并且耐受性很好.
结论:
- 透视式超声波导向排水,随后注入米诺环素化物,是症状性肝囊的可行和有效治疗方法.
- 这种技术特别有用,当穿皮进入具有挑战性或高风险时.
- 最少侵入性内镜治疗为精选的肝囊病例提供了对外科手术的有希望的替代方案.
更多相关视频
07:07Endoscopy Guided Photoablation of Endometrial Cysts using a 980 nm Laser with a Contact Fiber in Mares
Published on: July 16, 2020
4.3K
07:44Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
5.7K
相关概念视频
Chronic Pancreatitis II: Collaborative Care
79
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
79
Pleural Effusion II: Symptoms and Management
160
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
160
Cystic Fibrosis: Management
150
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
150
